Solstein Capital, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.

Quarter-by-quarter ownership
Solstein Capital, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2021$7,000
-91.6%
195
-90.8%
0.01%
-95.2%
Q3 2020$83,000
-92.1%
2,125
-92.5%
0.19%
-92.5%
Q2 2020$1,046,000
+459.4%
28,517
+346.3%
2.48%
+558.6%
Q4 2019$187,000
-0.5%
6,390
-41.9%
0.38%
-77.4%
Q3 2019$188,000
+46.9%
11,000
+120.0%
1.67%
+103.3%
Q2 2019$128,000
-57.8%
5,000
-63.0%
0.82%
-52.0%
Q1 2019$303,00013,5001.71%
Other shareholders
VANECK VECTORS ETF TR shareholders Q2 2021
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders